Fair Value Measurements - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |
---|---|---|---|
Sep. 30, 2020 |
Sep. 30, 2020 |
Dec. 31, 2019 |
|
Assets and liabilities measured at fair value on a recurring basis | |||
Marketable securities in deferred compensation plan | $ 2,672 | $ 2,672 | $ 3,060 |
Fair value measurement on a recurring basis | Deferred compensation plan | Trustees and Management | |||
Assets and liabilities measured at fair value on a recurring basis | |||
Maximum percentage of participants' compensation which is deferrable (as a percent) | 100.00% | ||
Marketable securities in deferred compensation plan | 2,700 | $ 2,700 | |
Fair Value, Nonrecurring | Baltimore, Maryland | |||
Assets and liabilities measured at fair value on a recurring basis | |||
Impairment losses | $ 1,500 |
X | ||||||||||
- Definition Represents the maximum percentage of participants' compensation that is deferrable by participants under the deferred compensation plan. No definition available.
|
X | ||||||||||
- Definition Carrying amount as of the balance sheet date of assets held under deferred compensation agreements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The charge against earnings in the period to reduce the carrying amount of real property to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|